biotech
biotech Articles
The health care sector was in trouble over the past year, under fire from congressional hearings and politicians on the campaign trail. However things look like they could be different in 2017.
Published:
Last Updated:
Shares of Cempra saw an incredible gain on Friday after the company announced the results from its late-stage trial for the treatment of patients with acute bacterial skin and skin structure...
Published:
Last Updated:
One area is dirt cheap now, and in some cases pays dividends and has big growth prospects, and that is the large cap biotechs.
Published:
Last Updated:
After a fresh capital raise of about $26 million, at least one analyst is calling for Sierra Oncology stock to more than double.
Published:
Last Updated:
A few biopharma companies have made massive runs on Tuesday morning.
Published:
Last Updated:
Alexion Pharmaceuticals released a mixed most recent earnings report before the markets opened on Thursday.
Published:
Last Updated:
The possibilities around gene editing are almost endless. Some of the goals and hopes around gene editing sound like they were pulled right out of a science fiction or futuristic film. Imagine if you...
Published:
Last Updated:
Shares of Sage Therapeutics saw a handy gain on Monday after the company announced a successful mid-stage trial for the treatment of major depressive disorder.
Published:
Last Updated:
After Gilead Sciences reported fourth-quarter earnings on Tuesday, the stock hit a new multiyear low and analysts took the opportunity to slash their price targets.
Published:
Last Updated:
As we approached Trump’s inauguration, the health care sector in general rallied. Now it’s time to see what the bears have to say about this rally.
Published:
Last Updated:
Shares of Acorda Therapeutics saw a hand gain in early trading on Thursday after the company reported results from its late-stage Parkinson’s trial.
Published:
Last Updated:
24/7 Wall St. has included some highlights from the Gilead Sciences earnings report, as well as what analysts are saying afterward.
Published:
Last Updated:
Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss.
Published:
Last Updated:
Gilead Sciences Inc. (NASDAQ: GILD) reported its fourth-quarter earnings after the markets closed on Tuesday. The company posted $2.70 in earnings per share (EPS) and $7.3 billion in revenue,...
Published:
Last Updated:
Gilead Sciences is set to report its fourth-quarter financial results after the markets close on Tuesday.
Published:
Last Updated: